1[2]Dubois D,Chanson P,Timsit J, et al.Remission of proteinuriafollowing corection of yperlipidemia in NIDDM patients with nondiabetic glomerulopathy.DIabetes Care 1994;17:906.
6Kuriyama S,Tomonari H,Abe A,et al. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy [ J]. Nephron,2000,86(4) :529-530.
7Mogensen CE, keane WF, Benntt PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria [ J]. Lancet, 1995,346(8982) : 1080-1084.
8Nosadini R, Velussi M, Brocco E, et al. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms[J]. Diabetes, 2005, 54 ( 1 ) : 228 -233.
9Benigni A, Gagliardini E, Tomasoni S, et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy [J]. Kidney Int, 2004, 65 ( 6 ) : 2193-2200.
10Ceol M, Gambaro G, Sauer U, et al Glycosaminoglycan therapy prevents TGF-betal 1 overexpression and pathologic changes in renal tissue of long term diabetic rats [ J ]. Am Soc Nephrol,2000,11 (12) :2324-2336.
